LEAP Protocol & MRT Interpretation Flashcards
7 cards from real CLT practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 LEAP Protocol & MRT Interpretation flashcards as text
During Phase 1 of the LEAP ImmunoCalm diet, approximately how long should a patient follow the initial elimination plan before foods are reintroduced?
Answer: 2–3 weeks
Phase 1 typically lasts 2–3 weeks to allow sufficient symptom reduction and inflammatory calm before yellow-zone foods are systematically reintroduced.
When reintroducing yellow-zone foods in Phase 2 of LEAP, which strategy is recommended?
Answer: Reintroduce one new food every 3–4 days while monitoring symptoms
Introducing one food every 3–4 days allows the clinician and patient to clearly attribute any symptom recurrence to a specific food.
Which symptom condition is NOT commonly reported as a LEAP/MRT-responsive condition?
Answer: Type 1 diabetes
Type 1 diabetes is an autoimmune disease driven by distinct mechanisms; LEAP/MRT therapy targets non-IgE-mediated food sensitivity conditions such as IBS, migraines, and fibromyalgia.
In the LEAP protocol, red-zone foods are typically introduced at what stage?
Answer: Only after Phase 2 reintroduction is complete and the patient is stable
Red-zone foods are the last to be reintroduced, if at all, after the patient has achieved stability and fully completed Phase 2.
A CLT designs a LEAP diet that rotates non-reactive foods across days. What is the primary purpose of rotation?
Answer: To prevent new sensitivities from developing through overexposure
Rotating foods prevents the immune system from being overexposed to any single food antigen, reducing the risk of developing new sensitivities during the elimination phase.
Which of the following best describes the term 'ImmunoCalm diet' within the LEAP framework?
Answer: A personalized diet built from each patient's lowest-reacting MRT foods
The ImmunoCalm diet is the individualized meal plan constructed from the patient's specific MRT green-zone (non-reactive) foods to calm immune-mediated inflammation.
If a patient reports symptom flare during Phase 2 reintroduction after adding a yellow-zone food, what should the CLT recommend?
Answer: Remove the newly added food, allow symptoms to resolve, then resume reintroduction with the next food
A symptom flare indicates that the reintroduced food is likely a trigger; removing it and waiting for resolution before continuing protects the data integrity of the reintroduction process.